Track topics on Twitter Track topics that are important to you
Atlanta, GA, USA – 14 March 2011 – Stratophase, a specialist in real-time chemical and biochemical measurement, will be exhibiting at this year’s Pittcon conference in Atlanta, USA (13th to 18th March). The Stratophase team will be present at booth 467, showcasing the latest developments in the company’s process status monitoring (PSM) and bio-detection solutions. Pittcon is the world's largest annual laboratory science conference and includes a significant number of presentations and short courses designed to provide education and field updates. In addition, this year’s exhibition will include more than 950 exhibitors discussing the latest technological developments.
At the Stratophase booth, the company’s expert team will be demonstrating the latest version of its bench-top PSM control unit, which is now even smaller and intuitive to use thanks to a 50% reduction in footprint and a touch-screen user interface. The unit can be connected to up to eight of Stratophase’s in-line optical sensors to provide real-time PSM of both batch and continuous flow reactions. In addition, Stratophase will also provide information on its bio-detection solutions. The platform specifically detects biological agents using a combination of the company’s innovative optical microchips with immunoassay-based chemistry, providing potential applications in fields as diverse as medicine, veterinary practices, agriculture and bio-defence. As an example of the system in use, Stratophase will provide data from a recent successful pilot study that utilised the technology to detect foot-and-mouth disease. To find out more, visit booth 467 or see Stratophase’s new and improved website at www.stratophase.com.
Stratophase is a VC-funded spin-out from the University of Southampton in the UK. Its unique SpectroSens technology is an optical microchip sensor which measures chemical processes and detects biological targets. This core optical measurement technology can be realised in a vast array of sensing heads, offering a wide variety of system configurations applicable to a broad spectrum of industries including chemical and biochemical production as well as biological detection.
The Stratophase team, guided by CEO Dr Richard Williams, includes the original inventors of the SpectroSens technology as well as senior managers with a vast array of industry experience.
Date 14 March 2011 Ref 1102SSTR
Product Enquiries Stratophase
Sam Watts – Business Development & Commercial Officer
t: +44 (0)1794 511226 e: email@example.com
Media enquiries Alto Marketing Limited
Paul Avery – Science Writer
t: +44 (0)1489 557672 e: firstname.lastname@example.org
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...